L14: Obesity, Metabolic Syndrome & Hyperlipidemia Flashcards
1
Q
Percentage of Fat in Obesity
A
2
Q
Obesity is a risk factor for ……
A
3
Q
Causes of Obesity
A
4
Q
what is the most common cause of obesity?
A
5
Q
Simple Obesity
A
6
Q
Etiopathogenesis of obesity
A
7
Q
Hypothalamic disorders causing obesity
A
8
Q
Endocrinal Causes of obesity
A
9
Q
Drugs causing obesity
A
10
Q
Rare genetic syndromes causing obesity
A
11
Q
Assessment of obesity
A
12
Q
BMI
A
13
Q
Method of measurment of Waist Circumference
A
14
Q
Threshold of Waist Circumference
A
15
Q
Estimation of body fat
A
16
Q
Types of Obesity
A
17
Q
Evaluation of an obese patient
A
18
Q
Benefits of weight loss
A
19
Q
Benefits of weight loss of > 5 kg
A
20
Q
Benefits of weight loss of 5-10%
A
21
Q
Aim of Managment of obesity
A
22
Q
Methods of Managment of obesity
A
23
Q
Methods of lifestyle modification
(Managment of obesity)
A
24
Q
Diet
A
25
Physical Activity
26
Indications of long-Term pharmacotherapy in obesity
27
Types of medications used in long-Term pharmacotherapy in obesity
28
Mechanism of **Peripherally acting drugs (Orlistat)**
29
Dose of **Peripherally acting drugs (Orlistat)**
30
SE of **Peripherally acting drugs (Orlistat)**
31
Newly approved medications in managment of obesity
32
MOA of Incretin based therapy
33
Examples of Incretin based therapy
34
Doses of GLP-1 receptor agonist
35
CI of incretin based therapy
35
SE of **incretin based therapy**
36
Bariatric surgery in managment of obesity
37
Def of **Metabolic Syndrome**
37
Dx of **Metabolic Syndrome**
38
Pathogenesis of **Metabolic Syndrome**
39
Managment of **Metabolic Syndrome**
40
Def of **Hyperlipidemia**
41
Types of **Hyperlipidemia**
42
Def of **Primary Hyperlipidemia**
43
Classification of **Primary Hyperlipidemia**
44
Types of **Hypercholesterolaemia**
45
Plasma lipid level in **Familial hypercholesterolemia**
46
Def of **Familial hypercholesterolemia**
47
CP of **Familial hypercholesterolemia**
48
Def of **Familial defective Apo B100**
49
Plasma lipid level in **Familial defective Apo B100**
50
CP of **Familial defective Apo B100**
51
Def of **Polygenic hypercholesterolemia**
52
Plasma lipid level of **Polygenic hypercholesterolemia**
53
CP of **Polygenic hypercholesterolemia**
54
Types of Hypertriglyceridaemia
55
Def of **Familial
hypertriglyceridemia**
56
PLL of **Familial
hypertriglyceridemia**
57
CP of **Familial
hypertriglyceridemia**
58
Def of **Familial lipoprotein
lipase deficiency**
59
PLL of **Familial lipoprotein
lipase deficiency**
60
CP of **Familial lipoprotein
lipase deficiency**
61
Def of **Familial Apo CII
deficiency**
62
PLL of **Familial Apo CII
deficiency**
63
CP of **Familial Apo CII
deficiency**
64
Types of **Combined hyperlipidaemia**
65
Def of **Familial Combined
hyperlipidemia**
66
PLL of **Familial Combined
hyperlipidemia**
67
CP of **Familial Combined
hyperlipidemia**
68
Def of **Dysbetalipoproteinemia**
69
CP of **Dysbetalipoproteinemia**
70
PLL of **Dysbetalipoproteinemia**
71
Def of **Secondary Hyperlipidemia**
72
Causes of **Secondary Hyperlipidemia**
73
Investigations for hyperlipidemia
74
Treatments for hyperlipidemia
75
General Measures in **Treatments for hyperlipidemia**
76
Drugs used in Treatments for hyperlipidemia
77
Drugs **If the predominant disturbance is cholesterol level**
78
Examples of **Statins**
79
MOA of **Statins**
80
SE of **Statins**
81
Examples of **Cholesterol absorption inhibitors**
82
MOA of **Cholesterol absorption inhibitors**
83
SE of **Cholesterol absorption inhibitors**
84
MOA of **Nicotinic acid**
85
Bile acid binding resins
86
Drugs If the predominant disturbance is triglycerides level
87
Examples of **Fibrates**
88
Uses of **Fibrates**
89
Examples of **Omega 3 fatty acids**
90
MOA of **Omega 3 fatty acids**
91
Uses of **Omega 3 fatty acids**
92
SE of Omega 3 fatty acids
